Literature DB >> 10878096

Evidence for cystic fibrosis transmembrane conductance regulator-dependent sodium reabsorption in kidney, using Cftr(tm2cam) mice.

J D Kibble1, A M Neal, W H Colledge, R Green, C J Taylor.   

Abstract

The aims of this study were to investigate (a) if renal Na(+) handling was normal in Cftr(tm2cam) delta F508 cystic fibrosis mice, (b) whether adaptation to dietary salt depletion was preserved and (c) whether Cftr(tm2cam) delta F508 mice exhibited enhanced amiloride-sensitive Na(+) absorption. In Na(+)-replete animals (maintained on a 0.32 % NaCl diet) given a 150 mM NaCl i.v. maintenance infusion, there was no difference in fractional Na(+) excretion (FE(Na)) between wild-type (0. 42 +/- 0.06 %, n = 12) and Cftr(tm2cam) delta F508 mice (0.47 +/- 0.13 %, n = 7). Amiloride infusion significantly increased FE(Na) in both wild-type (3.14 +/- 0.83 %, n = 6) and Cftr(tm2cam) delta F508 mice (3. 47 +/- 0.63 %, n = 9), though with no significant difference between genotypes. A 14 day dietary salt restriction (animals maintained on a 0.03 % NaCl diet) and maintenance infusion with a 15 mM NaCl vehicle caused a reduction in FE(Na) to 0.14 +/- 0.05 %, n = 8 in wild-type mice and 0.14 +/- 0.04 %, n = 8 in Cftr(tm2cam) delta F508 mice. No significant difference in the ability to adapt to low salt conditions was apparent comparing the two genotypes. Treatment of salt-restricted mice with amiloride resulted in a blunted natriuresis in both wild-type mice (FE(Na) = 1.10 +/- 0.16 %, n = 7) and Cftr(tm2cam) delta F508 mice (FE(Na) = 1.97 +/- 0.29 %, n = 9). The natriuresis induced by amiloride was significantly greater in Cftr(tm2cam) delta F508 mice than in wild-type controls. In conclusion, Cftr(tm2cam) delta F508 mice exhibit normal renal salt excretion when either salt replete or salt restricted. Enhanced amiloride-sensitive FE(Na) is consistent with increased Na(+) absorption via the amiloride-sensitive sodium channel ENaC, in cystic fibrosis kidney, but this was only observed during salt restriction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878096      PMCID: PMC2269995          DOI: 10.1111/j.1469-7793.2000.00027.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  31 in total

1.  Normalization of ion transport in murine cystic fibrosis nasal epithelium using gene transfer.

Authors:  L J MacVinish; C Goddard; W H Colledge; C F Higgins; M J Evans; A W Cuthbert
Journal:  Am J Physiol       Date:  1997-08

2.  Immunocytochemical localization of the cystic fibrosis gene product CFTR.

Authors:  I Crawford; P C Maloney; P L Zeitlin; W B Guggino; S C Hyde; H Turley; K C Gatter; A Harris; C F Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 3.  Ion transporter mutations in Gitelman's and Bartter's syndromes.

Authors:  D B Simon; R P Lifton
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-01       Impact factor: 2.894

Review 4.  The ROMK-cystic fibrosis transmembrane conductance regulator connection: new insights into the relationship between ROMK and cystic fibrosis transmembrane conductance regulator channels.

Authors:  K Ho
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-01       Impact factor: 2.894

5.  Model explaining the relation between distal nephron Li+ reabsorption and urinary Na+ excretion in rats.

Authors:  M Shalmi; T Jonassen; K Thomsen; J D Kibble; P Bie; S Christensen
Journal:  Am J Physiol       Date:  1998-03

6.  cAMP stimulates CFTR-like Cl- channels and inhibits amiloride-sensitive Na+ channels in mouse CCD cells.

Authors:  B Letz; C Korbmacher
Journal:  Am J Physiol       Date:  1997-02

7.  Enhanced colonic Na+ absorption in cystic fibrosis mice versus normal mice.

Authors:  B R Grubb; R C Boucher
Journal:  Am J Physiol       Date:  1997-02

8.  Chloride currents activated by calcitonin and cAMP in primary cultures of rabbit distal convoluted tubule.

Authors:  M Tauc; M Bidet; P Poujeol
Journal:  J Membr Biol       Date:  1996-04       Impact factor: 1.843

9.  Defective proximal tubular fluid reabsorption in transgenic aquaporin-1 null mice.

Authors:  J Schnermann; C L Chou; T Ma; T Traynor; M A Knepper; A S Verkman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

Authors:  M Mall; M Bleich; R Greger; R Schreiber; K Kunzelmann
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

View more
  6 in total

Review 1.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 2.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

3.  Renal proximal tubule function is preserved in Cftr(tm2cam) deltaF508 cystic fibrosis mice.

Authors:  J D Kibble; K J Balloch; A M Neal; C Hill; S White; L Robson; R Green; C J Taylor
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

4.  Molecular and functional characterization of the cystic fibrosis transmembrane conductance regulator from the Australian common brushtail possum, Trichosurus vulpecula.

Authors:  K J Demmers; D Carter; S Fan; P Mao; N J Maqbool; B J McLeod; R Bartolo; A G Butt
Journal:  J Comp Physiol B       Date:  2009-12-12       Impact factor: 2.200

Review 5.  CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis.

Authors:  François Jouret; Olivier Devuyst
Journal:  Pflugers Arch       Date:  2008-10-07       Impact factor: 3.657

Review 6.  Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling.

Authors:  Lichao Hu; Mengyuan Ding; Weichun He
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.